ES2058903T3 - Nuevo uso de somatostatina. - Google Patents

Nuevo uso de somatostatina.

Info

Publication number
ES2058903T3
ES2058903T3 ES90905511T ES90905511T ES2058903T3 ES 2058903 T3 ES2058903 T3 ES 2058903T3 ES 90905511 T ES90905511 T ES 90905511T ES 90905511 T ES90905511 T ES 90905511T ES 2058903 T3 ES2058903 T3 ES 2058903T3
Authority
ES
Spain
Prior art keywords
treatment
somatostatin
prevention
somatostatina
new use
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90905511T
Other languages
English (en)
Inventor
Manuel Rodriguez Puyol
Diego Rodriguez Puyol
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Applied Research Systems ARS Holding NV
Original Assignee
Applied Research Systems ARS Holding NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems ARS Holding NV filed Critical Applied Research Systems ARS Holding NV
Application granted granted Critical
Publication of ES2058903T3 publication Critical patent/ES2058903T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/31Somatostatins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

EL INVENTO PROVEE COMPOSICIONES FARMACEUTICAS PARA USO EN LA PREVENCION O TRATAMIENTO DE ENFERMEDADES Y DISFUNCIONES ASOCIADAS CON LA CONTRACCION PATOLOGICA DE CELULAS MESANGIALES Y OTRAS CELULAS CONTRACTILES SENSIBLES AL ANGIOTESTIN II Y/O RADICALES LIBRES DE OXIGENO, COMPRENDIENDO COMO INGREDIENTE ACTIVO UNO O MAS POLIPEPTIDOS ACTIVOS DE SOMATOSTATIN. EL SOMATOSTATIN ES PARTICULARMENTE UTIL PARA EL TRATAMIENTO O PREVENCION DE DISFUNCIONES RENALES. EL INVENTO TAMBIEN INCLUYE EL USO DE POLIPEPTIDOS ACTIVOS DE SOMATOSTATIN PARA LA PREPARACION DE TALES COMPONENTES Y LOS METODOS CORRESPONDIENTES DE TRATAMIENTO DE HUMANOS Y ANIMALES.
ES90905511T 1989-04-14 1990-04-13 Nuevo uso de somatostatina. Expired - Lifetime ES2058903T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898908457A GB8908457D0 (en) 1989-04-14 1989-04-14 Pharmaceutical compositions and uses therefor

Publications (1)

Publication Number Publication Date
ES2058903T3 true ES2058903T3 (es) 1994-11-01

Family

ID=10655037

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90905511T Expired - Lifetime ES2058903T3 (es) 1989-04-14 1990-04-13 Nuevo uso de somatostatina.

Country Status (8)

Country Link
EP (1) EP0422156B1 (es)
JP (1) JP2889374B2 (es)
AT (1) ATE94074T1 (es)
DE (1) DE69003216T2 (es)
DK (1) DK0422156T3 (es)
ES (1) ES2058903T3 (es)
GB (1) GB8908457D0 (es)
WO (1) WO1990012589A1 (es)

Also Published As

Publication number Publication date
WO1990012589A1 (en) 1990-11-01
DE69003216D1 (de) 1993-10-14
DE69003216T2 (de) 1994-01-27
JP2889374B2 (ja) 1999-05-10
EP0422156B1 (en) 1993-09-08
JPH04506341A (ja) 1992-11-05
GB8908457D0 (en) 1989-06-01
ATE94074T1 (de) 1993-09-15
EP0422156A1 (en) 1991-04-17
DK0422156T3 (da) 1994-01-10

Similar Documents

Publication Publication Date Title
DE59905954D1 (de) Dialkylfumarate zur behandlung von autoimmunerkrankungen
DE69027865D1 (de) ZUSAMMENSETZUNGEN enthaltend omega Conotoxin Peptide Derivate und deren Verwendung ZUR BEHANDLUNG VON ISCHÄMIE-ARTIGEN NEURONALEN SCHÄDIGUNGEN
EA199800946A1 (ru) Концентрированный препарат антител
BG103575A (en) SUBSTITUTED NITROGENCONTAINING HETEROCYCLES AS p38 PROTEINKINASE INHIBIRORS
IT8547852A0 (it) Ciclosporine,processi per la loro preparazione,uso farmaceutico delle stesse e composizioni farmaceutiche che le contengono
FI970810A0 (fi) Ionipolymeerejä sisältäviä biologisesti aktiivisia anioneja
NO157020C (no) AnalogifremgangsmŸte ved fremstilling av terapeutisk aktive 3,20-dioxo-1,4-pregnadien-17alfa-ol-17-aromatiske heterocykliske carboxylater.
NO158741C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kvartaere dibenzotiepin-n-alkyl-norskopinetere.
MX9102353A (es) N,o-sulfados de heparosanos, su procedimiento de preparacion y las composiciones farmaceuticas que contienen.
MY110217A (en) Use of l-deprenyl for retarding deterioration due to aging in dogs
DK1228097T3 (da) Antimikrobiel aktivitet af den förste kationiske humane lactoferrin-klynge
TR200100637T2 (tr) Yeni doğal ürün türevleri
BG93298A (bg) Имуностимулиращи 6-арил-5,6-дихидроимидазо(2,1-в)тиазолови производни
ITRM950273A0 (it) Antagonisti di interluchina-6 umana del tutto incapaci di formare un legame con gp 130, e loro uso per la preparazione di composizioni farmaceutiche.
ES2058903T3 (es) Nuevo uso de somatostatina.
ES495459A0 (es) Procedimiento para la obtencion de nuevos carbamatos
YU39396A (sh) Upotreba izolovanog prirodnog proteina gojaznosti za pripremu leka i njegova farmaceutska formulacija
EA199901061A1 (ru) Новые соли врс-пептидов с органопротективной активностью, способ их получения и их использование в терапии
IT8067738A0 (it) Procedimento per la preparazione di tetraido pirrolo [1,2-a] pirimidine 3-sostituite, composizioni farmaceutiche che le contengono e tetraidro pirrolo [1,2-a] pirimidine 3-sostituite
SE8402199D0 (sv) Pharmazeutisches preparat enthaltend co-dergocrine und einen calcium-antagonisten
IT8620643A0 (it) Grasso autoemulsionante per uso farmaceutico e cosmetico, sua preparazione ed uso.
BR9812489A (pt) Uso de 6,7-substituìdas-2-aminotetralinas adequadas para a preparação de uma composição farmacêutica para o tratamento terapêutico de patologias inflamatórias e/ou autoimunes
DK0391224T3 (da) Lægemiddel og anvendelse heraf til behandling af parasitoser
IT8219652A0 (it) Derivato della propionilglicina, processi per la sua preparazione e composizioni terapeutiche che lo contengono come principio attivo.
AR026475A1 (es) Una pirazolotriazina sustituida como agonista inverso selectivo apra el subtipo de receptor de gaba-a alfa 5

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 422156

Country of ref document: ES